Search

Your search keyword '"Faber, C. G."' showing total 164 results

Search Constraints

Start Over You searched for: Author "Faber, C. G." Remove constraint Author: "Faber, C. G."
164 results on '"Faber, C. G."'

Search Results

1. Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)

3. Clinical improvement of DM1 patients reflected by reversal of disease-induced gene expression in blood.

4. Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity

5. Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses

6. Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar

7. Outcome measures in MMN revisited: further improvement needed

8. Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison

9. Rasch-ionale for neurologists

10. Rasch-built Overall Disability Scale for Multifocal motor neuropathy (MMN-RODS©)

11. The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

12. Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome. An international observational study

17. Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin

20. Second IVIg course in Guillain-Barré syndrome with poor prognosis. The non-randomised ISID study

27. Current treatment practice of Guillain-Barré syndrome

29. Duchenne-Spierdystrofie

30. Second IVIg course in Guillain-Barre syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial

32. Current treatment practice of Guillain-Barré syndrome

33. Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands

34. Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study

37. Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)

38. Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies

39. The minimum clinically important difference: which direction to take.

40. Small fibre neuropathy in sarcoidosis

41. Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies

43. Provider perceptions of clinical neuropathy examination usefulness

44. Genetic aspects of sodium channelopathy in small fiber neuropathy

47. Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study

48. Treatment of Guillain-Barre syndrome with mycophenolate mofetil: a pilot study (vol 78, pg 1012, 2007)

Catalog

Books, media, physical & digital resources